CHILDREN with deadly brain tumours could get an 18-month survival boost with the first new NHS drug for almost 20 years. The medicines watchdog has approved the gene-targeting drug combination of d Read this story
CHILDREN with deadly brain tumours could get an 18-month survival boost with the first new NHS drug for almost 20 years. The medicines watchdog has approved the gene-targeting drug combination of d Read this story
More from The Scottish Sun | Section: Health:News Health Cancer Children parenting and family life NHS England Health News Health